Brief: Oncoarendi Therapeutics Gets 22.4 Mln Zloty Subsidy From NCBR For Development Of OATD-01 Drug Candidate

Molecure SA

26/11/2019 15:03

Nov 26 (Reuters) - Oncoarendi Therapeutics SA  OAT.WA :
    * GETS 22.4 MILLION ZLOTY SUBSIDY FROM NCBR
    * SAID SUBSIDY IS FOR DEVELOPMENT OF OATD-01 DRUG CANDIDATE
TO USE
IN PATIENTS WITH SARCOIDOSIS

Source text for Eikon:  ID:nEM4HJG0ja 
Further company coverage:  OAT.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))